IDH2 and cholangiocarcinoma: IDH mutations have been implicated in other cancer types, including AML, myelodysplastic syndrome (15–18), cholangiocarcinoma of intrahepatic origin (53), central and periosteal cartilaginous chondrosarcomas (54), and melanoma (55, 56).